推荐应用
B7-H7, also known as HHLA2 (HERV-H LTR-associating 2), is a member of the B7 family of immune regulatory proteins. Mature human B7-H7 consists of a 322 amino acid (aa) extracellular domain (ECD) with three immunoglobulin-like domains, a 21 aa transmembrane segment, and a 49 aa cytoplasmic domain. B7H7 is constitutively expressed on monocytes and is up-regulated by LPS and IFN-gamma stimulation. It is expressed on LPS/IFN-gamma treated B cells but not on resting B cells. B7-H7 binds to cell surface determinants on resting and mature T cells, B cells, and monocytes as well as on immature and mature dendritic cells. Soluble B7-H7 inhibits the proliferation of activated CD4+ and CD8+ T cells and their production of IFN-gamma, TNF-alpha, IL-5, IL-10, IL-13, IL-17A, and IL-22.
高纯度、高活性、低内毒素、高批间一致性
Tris-Bis PAGE

-25 ~ -15℃保存,收到货之后有效期1年。 复溶后, 无菌条件下,-85 ~ -65℃保存,3个月有效期。
【应用方向】BCMA/TNFRSF17:多发性骨髓瘤免疫治疗的核心靶点蛋白
81
2026-08-31
【应用方向】CD20:B细胞恶性肿瘤免疫治疗的核心靶点蛋白
76
2026-08-31
【应用方向】CD19:血液肿瘤免疫治疗的核心靶点蛋白
85
2026-08-31
【应用方向】免疫检查点核心家族:B7-CD28超家族蛋白
990
2026-04-21
【应用方向】TIM-3:下一代肿瘤免疫检查点治疗的核心靶点
718
2026-04-21
【应用方向】SIRP家族分子详解与产品选择指南
612
2026-04-21
【应用方向】OX40-OX40L共刺激轴的T细胞存活调控
675
2026-04-21
【应用方向】LILRB家族:髓系细胞免疫检查点的研究前沿与产品解决方案
906
2026-04-21
【应用方向】LAG-3(CD223):T细胞耗竭调控网络的核心节点
810
2026-04-21
【应用方向】B7-H3(CD276):双重功能免疫检查点的分子特征与科研应用
1328
2026-04-20





